Clinical decision support for chemotherapy‐induced neutropenia using a hybrid pharmacodynamic/machin...
Clinical decision support for chemotherapy‐induced neutropenia using a hybrid pharmacodynamic/machine learning model
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Consensus guidelines recommend use of granulocyte colony stimulating factor in patients deemed at risk of chemotherapy‐induced neutropenia, however, these risk models are limited in the factors they consider and miss some cases of neutropenia. Clinical decision making could be supported using models that better tailor their predictions to the indiv...
Alternative Titles
Full title
Clinical decision support for chemotherapy‐induced neutropenia using a hybrid pharmacodynamic/machine learning model
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9b8e71992abd4dd09f32dfcfc7182e68
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b8e71992abd4dd09f32dfcfc7182e68
Other Identifiers
ISSN
2163-8306
E-ISSN
2163-8306
DOI
10.1002/psp4.13019
